跳至主要内容
临床试验/JPRN-UMIN000016993
JPRN-UMIN000016993已完成未知

Exploratory study for SGLT2 inhibitor -Glucose lowering action, influences of dietary habits/exercise habits on therapeutic effects, and treatment satisfaction - Canak

Kanagawa Physicians Association0 个研究点目标入组 150 人开始时间: 2015年3月31日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Received SGLT 2 inhibitors within 6 months before providing consent 2) Type 1 diabetes 3) Severe ketosis, diabetic coma or precoma within 6 months 4) Treatment with Insulin preparation and/or GLP -1 receptor agonist 5) Severe infection, been pre-/post-surgery, and serious trauma 6) Severe hepatic dysfunction 7) Moderate or severe renal dysfunction 8) Hypersensitivity to any ingredient of the study drug 9) Urinary tract infection and genital infection 10) Contraindications to undergoing oral hypoglycemic agents (DPP-4 inhibitor, Sulfonylurea, Metformin etc.) 11) Enrolled in other current clinical trials 12) Pregnancy, nursing and possibility of pregnant or plan to pregnant 13) Considered as inadequate by the principal investigator or investigator

研究者

发起方
Kanagawa Physicians Association

相似试验